Key Points Hims & Hers is an exciting stock in the telehealth sector, but as a growth stock, it’s not for the faint of heart.

Otherwise, this looks like a fantastic growth stock that just doubled its addressable market with the Zava acquisition. Today ...

By Amina Niasse (Reuters) -Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up ...

Taylor Swift's WAG era has included far fewer Chanel bag sightings than custom Chiefs merch. She wore a head-to-toe, $16,500 ...

Hims & Hers Health has seen massive success, aided by the growing use of GLP-1 drugs. Click here to find out why I downgrade ...

Per the chart above, roughly 35% of Hims & Hers float is sold short. Investors who short a stock are betting its price will fall. Short interest of 10% or more is considered unusually high. Not only ...

Hims & Hers leverages ZAVA's expertise to enter Europe's weight-loss market, boosting growth and profitability. Read what ...

Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Tuesday after the company announced an acceleration of its ...

Tuesday, online health and wellness company Hims & Hers announced its intent to acquire European digital healthcare provider ...

Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...